Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Bon Natural Life Limited Announces Record First Half-Year Revenue and Net Income


      News provided by

      Bon Natural Life Limited

      Aug 01, 2022, 08:30 ET

      Share this article

      Share this article


      1H-2022 Revenue increases by 17.0% to $13.7 million

      XI'AN, China, Aug. 1, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its half-year financial results for the six months ended March 31, 2022.

      1H-2022 Financial Highlights

      • Total net revenues were US$13.7 million, representing a 17.0% increase from US$11.7 million for the same period in 2021.
      • Gross profit increased by 19.6% to US$4.0 million from US$3.4 million for the same period in 2021.
      • Gross margin was 29.5%, an increase by 70 basis points from 28.8% for the same period in 2021, and an increase by 2.4% sequentially compared to that of the six months ended September 30, 2021.
      • Sales volumes and gross profit of our bioactive food ingredient products increased by 47.5% and 191.1% compared to the same period of 2021.
      • Net income increased by 10.2% to US$2.5 million from US$2.3 million for the same period in 2021.
      • Diluted earnings per share ("EPS") was $0.30, compared to $0.40 for the same period in 2021.
      • Diluted weighted-average number of ordinary shares outstanding increased to 8,386,306 from 5,800,000 for the same period in 2021 due to more shares issued in connection with IPO.

      Management Commentary

      "We are pleased with a strong start to 2022 and a positive momentum across many of our new initiatives despite unprecedented challenges caused by the pandemic and the most recent macro-economic conditions." Said Richard (Yongwei) Hu, BON's Chairman & CEO, "I am incredibly proud of our teams' achievements to adapt these conditions and help offset pressures over time by our pricing actions, in combination with our continuing cost discipline and market strategy adjustment. In the first six months of the current fiscal year, the average selling prices of fragrance compound, health supplemental powder drinks and bioactive food ingredients increased by 64.1%, 11.2% and 79.2% year over year, respectively, as we effectively passed through the rising raw material costs downstream by raising our selling prices on top of our product mix shift to higher value added and higher margin products. We are encouraged by the positive trending of our gross margin, which has been on a stable upward trajectory and expanded 2.4% sequentially."

      "We are excited about the multiple near term catalysts ahead of us. In this fiscal half year, we kept investing in our future and our third production base, Yumen plant is on track to complete construction as scheduled and expected to be operational in the fourth quarter of 2022. Once up and running, Yumen plant will add 200% increase in production capacity in fragrance compounds and bioactive food ingredients and 150% overall revenue growth potential on an annualized basis. In addition, with the successful rollout of our new proprietary vegetable based probiotic powder drink for regulation and improvement of human's overall microbiome and digestive health, stachyose and apple extract based personal care product for female hygiene health, we are expecting growing demand from natural and health -conscious consumers. Our new Yumen Plant and the expansion of Tongchuan plant, coupled with our new product initiatives will enable us to meet more customer demand efficiently, accelerate our global business expansion and deliver lasting long-term value for our shareholders."

      1H-2022 Product Categories Summary: Growth vs. Prior Year


      Revenues increase
      (decrease)

      Gross Profits increase
      (decrease)

      Fragrance Compounds

      24.9 %

      53.9 %

      Health Supplements (Powder Drinks)

      (28.5 %)

      (36.4 %)

      Bioactive Food Ingredients

      171.8 %

      191.1 %

      Fragrance Compounds

      Revenue from sales of fragrance compound products increased by 24.9% to US$7.4 million from US$6.0 million for the same period in 2021. The increase was primarily attributable to a 64.1% increase in average selling price driven by our product mix shift towards higher value added and higher margin products, such as ambroxide, a key ingredient of fragrance, as well as a 2.8% positive impact from currency exchange, partially offset by a decrease of 26.0% in sales volume due to shortage of material supply.

      Gross profit from fragrance compound increased by 53.9% from US$1.2 million to US$1.8 million for the same period in 2021. The increase was attributable to the above referenced factors.

      Health Supplements (Powder Drinks)

      Revenue from sales of health supplement (powder drinks) products decreased by 28.5% to US$3.3 million from US$4.7 million for the same period in 2021. The decrease was primarily attributable to the decrease in sales volume due to material supply shortage, partially offset by increase in average selling price and positive impact from currency exchange.

      Gross profit from health supplement (powder drinks) decreased by 36.4% from US$1.8 million to US$1.2 million for the same period in 2021. The decrease was mainly due to the decrease in sales volume and increase in weighted average unit cost, partially offset by positive impact from currency exchange.

      Bioactive Food Ingredients

      Revenue from sales of bioactive food ingredient products increased by 171.8% to US$2.9 million from US$1.1 million for the same period in 2021. The increase was mainly attributable to 79.2% and 47.5% increase in average selling price and sales volume due to strong customer demand and sales effort as well as a 2.8% positive impact from currency exchange.

      Gross profit of our bioactive food ingredient products increased by 191.1% to $1.1 million from $365,867 for the same period in 2021. This increase was primarily due to the above referenced factors.

      General and administrative expenses increased by $319,308, or approximately 47.0%, from $679,635 in the six months ended March 31, 2021, to $998,943 in the same period of 2022, mainly attributable to increase of $335,265 in professional service fees such as directors' and officers' liability insurance, investor relations management, etc. as we become a public company since we completed the IPO in July 2021.

      Research and development ("R&D") expenses increased by $57,677, or approximately 53.9%, from $106,998 in the six months ended March 31, 2021, to $164,675 in the same period of 2022. The increase was mainly due to an increase of $69,022 in outsourcing R&D activities to external consulting firms.

      Government subsidies received in the form of a grant and recognized as other operating income totaled $542,256 and $446,910 in the six months ended March 31, 2022 and 2021, respectively.

      Net income increased from $2.3 million in the six months ended March 31, 2021 to $2.5 million in the same period of 2022.

      Net cash used in operating activities during the six months ended March 31, 2022 was $130,577 compared to net cash provided in operating activities of $2.0 million in the same period of 2021.

      Diluted earnings per share ("EPS") was $0.30, compared to $0.40 for the same period in 2021.

      Investors are encouraged to review the Company's complete financial statements and related disclosures for additional information.  These materials are available at https://www.sec.gov/edgar/browse/?CIK=1816815&owner=exclude.

      Subsequent Events

      On May 5, 2022, the Company announced that its third production site – Yumen Plant has completed the building structure of the facility as scheduled and forecasted to commence around September 2022.

      On June 16, 2022, the Company launched a new cruciferous vegetable based probiotic powder drink that could help regulate digestive system.

      Effective June 28, 2022, Jeffery Guzy was appointed as a new independent Director to the Company's Board of Directors and as Chair of the Audit Committee. Mr. Christopher Constable resigned as a director of the Company for personal reasons and stepped down as a member and chairman of the audit committee of the Board.

      Investor Conference Call and Webcast

      A live webcast to discuss the Company's 1H 2022 financial results will be held on August 1, 2022, beginning at 9:00 a.m. EST. The webcast and accompanying slide presentation may be accessed on the Company's IR website at https://ir.bnlus.com/events-presentations/. The webcast also can be accessed by using the direct link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=1sM1QUxQ

      For those unable to listen to the live webcast, a recorded version will be available on the Company's website after the event.

      Pre-registration: https://dpregister.com/sreg/10169993/f3e46b2118

      Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the operator. Participants may pre-register at any time, up to and including after the time that the call has started.

      Those without internet access or unable to pre-register may dial in by calling:

      U.S. Toll Free: 1-866-777-2509 | International Toll: 1-412-317-5413

      About Bon Natural Life Limited

      The Company focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds for perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by their customers. For additional information, please visit the Company's website at www.bnlus.com.

      Safe Harbor Statement

      This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the natural, health and personal care market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

      For more information, please contact:

      In the United States: 


      Maggie Zhang | Impact IR   

      Sophie Zhang | Impact IR

      Phone: (646) 893-8916 

      Phone: (786) 953-2513     

      Email: [email protected]

      Email: [email protected]

      BON NATURAL LIFE LIMITED AND SUBSIDIARIES

      CONDENSED CONSOLIDATED BALANCE SHEETS

      (UNAUDITED)








      As Of




      March 31, 2022



      September 30,
      2021


      ASSETS









      CURRENT ASSETS









      Cash


      $

      1,609,079



      $

      1,903,867


      Short-term investments



      132,114




      1,703,314


      Accounts receivable, net



      7,534,786




      6,152,807


      Inventories, net



      2,143,385




      1,596,492


      Advance to suppliers, net



      3,187,116




      4,094,312


      Deferred offering costs



      -




      -


      Acquisition deposit



      1,000,000




      1,000,000


      Prepaid expenses and other current assets



      95,286




      98,960


      TOTAL CURRENT ASSETS



      15,701,766




      16,549,752











      Property, plant and equipment, net



      23,069,191




      19,228,642


      Intangible assets, net



      416,024




      411,056


      Right-of-use lease assets, net



      171,380




      201,007


      Deferred tax assets, net



      22,774




      22,342


      TOTAL ASSETS


      $

      39,381,135



      $

      36,412,799











      LIABILITIES AND EQUITY









      CURRENT LIABILITIES









      Short-term loans


      $

      1,615,503



      $

      41,381


      Current portion of long-term loans



      1,845,275




      448,005


      Accounts payable



      553,750




      380,385


      Due to related parties



      272,942




      245,104


      Taxes payable



      3,328,986




      5,052,018


      Deferred revenue



      673,974




      1,096,101


      Accrued expenses and other current liabilities



      73,710




      41,711


      Finance lease liabilities, current



      114,216




      161,286


      Operating lease liability, current



      69,167




      62,871


      TOTAL CURRENT LIABILITIES


      $

      8,547,523



      $

      7,528,862


      Long-term loans



      1,080,402




      2,173,532


      Finance lease liabilities, noncurrent



      -




      28,953


      Operating lease liability, noncurrent



      113,478




      146,703


      TOTAL LIABILITIES



      9,741,403




      9,878,050











      COMMITMENTS AND CONTINGENCIES









      EQUITY









      Ordinary shares, $0.0001 par value, 500,000,000 shares authorized,
      8,350,381 and 8,330,000 shares issued and outstanding as of
      March 31, 2022 and September 30, 2021, respectively


      $

      835



      $

      833


      Additional paid in capital



      15,630,251




      15,540,433


      Statutory reserve



      1,050,721




      1,050,721


      Retained earnings



      11,741,354




      9,192,676


      Accumulated other comprehensive income



      710,020




      222,221


      TOTAL BON NATURAL LIFE LIMITED SHAREHOLDERS'
      EQUITY



      29,133,181




      26,006,884


      Non-controlling interest



      506,551




      527,865


      Total equity



      29,639,732




      26,534,749


      TOTAL LIABILITIES AND EQUITY


      $

      39,381,135



      $

      36,412,799


      BON NATURAL LIFE LIMITED AND SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

      (UNAUDITED)















      For the six months ended

      March 31,




      2022



      2021


      REVENUE


      $

      13,688,400



      $

      11,698,830


      COST OF REVENUE



      (9,652,453)




      (8,325,148)


      GROSS PROFIT



      4,035,947




      3,373,682











      OPERATING EXPENSES









      Selling expenses



      (83,970)




      (52,666)


      General and administrative expenses



      (998,943)




      (679,635)


      Research and development expenses



      (164,675)




      (106,998)


      Total operating expenses



      (1,247,588)




      (839,299)











      INCOME FROM OPERATIONS



      2,788,359




      2,534,383











      OTHER INCOME (EXPENSES)









      Interest income



      589




      294


      Interest expense



      (277,764)




      (197,168)


      Unrealized foreign transaction exchange loss



      (16,994)




      (65,691)


      Government subsidies



      542,256




      446,910


      Income from short-term investments



      12,419




      -


      Other income



      43,532




      41,548


      Total other income, net



      304,038




      225,893











      INCOME BEFORE INCOME TAX PROVISION



      3,092,397




      2,760,276











      INCOME TAX PROVISION



      (562,737)




      (465,077)











      NET INCOME



      2,529,660




      2,295,199


      Less: net loss attributable to non-controlling interest



      (19,018)




      (16,200)


      NET INCOME ATTRIBUTABLE TO BON NATURAL LIFE
      LIMITED


      $

      2,548,678



      $

      2,311,399











      NET INCOME



      2,529,660




      2,295,199











      OTHER COMPREHENSIVE INCOME









      Total foreign currency translation adjustment



      485,503




      406,143


      TOTAL COMPREHENSIVE INCOME



      3,015,163




      2,701,342


      Less: comprehensive loss attributable to non-controlling interest



      (21,314)




      (13,580)


      COMPREHENSIVE INCOME ATTRIBUTABLE TO BON
      NATURAL LIFE LIMITED


      $

      3,036,477



      $

      2,714,922











      EARNINGS PER SHARE









      Basic


      $

      0.31



      $

      0.40


      Diluted


      $

      0.30



      $

      0.40











      WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING









      Basic



      8,350,381




      5,800,000


      Diluted



      8,386,306




      5,800,000


      BON NATURAL LIFE LIMITED AND SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (UNAUDITED)






      For the six months ended

      March 31,




      2022



      2021


      Cash flows from operating activities









      Net income


      $

      2,529,660



      $

      2,295,199


      Adjustments to reconcile net income to cash provided by operating
      activities









      Allowance for doubtful accounts



      187




      6,323


      Depreciation and amortization



      112,945




      117,888


      Deferred income tax



      (28)




      13,879


      Amortization of operating lease right-of-use assets



      33,122




      26,195


      Amortization of stock options



      89,820




      -


      Unrealized foreign currency exchange loss



      16,994




      65,691


      Gain on disposal of property and equipment



      (745)




      -


      Changes in operating assets and liabilities:









      Accounts receivable



      (1,265,109)




      (2,898,493)


      Inventories



      (515,690)




      (391,958)


      Advance to suppliers, net



      977,033




      1,738,442


      Prepaid expenses and other current assets



      (38,795)




      (99,108)


      Accounts payable



      165,741




      (760,103)


      Operating lease liabilities



      (30,589)




      (21,975)


      Taxes payable



      (1,806,543)




      1,120,847


      Deferred revenue



      (440,032)




      403,246


      Accrued expenses and other current liabilities



      41,452




      383,696


      Net cash provided by (used in) operating activities



      (130,577)




      1,999,769











      Cash flows from investing activities









      Purchase of short-term investments



      (3,678,199)




      -


      Proceeds upon redemption of short-term investments



      5,273,186




      -


      Purchase of property and equipment



      (10,231)




      (715)


      Proceeds from sales of property and equipment



      1,659






      Capital expenditures on construction-in-progress



      (3,577,995)




      -


      Net cash used in investing activities



      (1,991,580)




      (715)











      Cash flows from financing activities









      Proceeds from short-term loans



      1,608,378




      943,517


      Proceeds from long-term loans



      594,864




      685,067


      Repayment of short-term loans



      (41,945)




      (457,729)


      Repayment of long-term loans



      (339,343)




      (109,382)


      Proceeds from (repayment of) borrowings from related parties



      91,965




      (1,391,813)


      Proceeds from (repayment of) third party loans



      -




      (716,574)


      Principal payment from (repayment of) capital lease



      (89,465)




      254,970


      Payment for deferred offering costs



      -




      (155,557)


      Net cash provided by (used in) financing activities



      1,824,454




      (947,501)











      Effect of changes of foreign exchange rates on cash



      2,915




      (64,052)


      Net increase (decrease) in cash



      (294,788)




      987,501


      Cash, beginning of year



      1,903,867




      53,106


      Cash, end of year


      $

      1,609,079



      $

      1,040,607











      Supplemental disclosure of cash flow information









      Cash paid for interest expense


      $

      277,764



      $

      215,268


      Cash paid for income tax


      $

      785,853



      $

      1,424


      Supplemental disclosure of non-cash investing and financing activities









      Amortization of share-based compensation for initial public offering
      services


      $

      89,820



      $

      316,668


      Right-of-use assets obtained in exchange for operating lease
      obligations


      $

      -



      $

      255,811


      SOURCE Bon Natural Life Limited

      Modal title

      Also from this source

      BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives

      Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal...

      BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market

      Bon Natural Life Limited (Nasdaq: BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal...

      More Releases From This Source

      Explore

      Banking & Financial Services

      Banking & Financial Services

      Supplementary Medicine

      Supplementary Medicine

      Health Care & Hospitals

      Health Care & Hospitals

      Food & Beverages

      Food & Beverages

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.